Use of hormonal contraceptives and risk of HIV-1 transmission
Gray, R.H.
Lancet. Infectious Diseases 12(7): 507; Author Reply 510-1
2012
ISSN/ISBN: 1473-3099 PMID: 22742627 DOI: 10.1016/s1473-3099(12)70111-1Document Number: 552679
Document emailed within 0-6 h
Related Documents
van Leeuwen, R.W.; de Vries, F. 2012: Use of hormonal contraceptives and risk of HIV-1 transmission Lancet. Infectious diseases 12(7): 508-9; author reply 510-1van Leeuwen, R.W.; de Vries, F. 2012: Use of hormonal contraceptives and risk of HIV-1 transmission Lancet. Infectious diseases 12(7): 508-9; author reply 510-1
van Leeuwen, R.W.; de Vries, F. 2012: Use of hormonal contraceptives and risk of HIV-1 transmission Lancet. Infectious diseases 12(7): 508-9; author reply 510-1
van Leeuwen, R.W.; de Vries, F. 2012: Use of hormonal contraceptives and risk of HIV-1 transmission Lancet. Infectious diseases 12(7): 508-9; author reply 510-1
van Leeuwen, R.W.; de Vries, F. 2012: Use of hormonal contraceptives and risk of HIV-1 transmission Lancet. Infectious diseases 12(7): 508-9; author reply 510-1
Gray, R.H. 2012: Use of hormonal contraceptives and risk of HIV-1 transmission Lancet. Infectious Diseases 12(7): 507; Author Reply 510-1
Gray, R.H. 2012: Use of hormonal contraceptives and risk of HIV-1 transmission Lancet. Infectious Diseases 12(7): 507; Author Reply 510-1
Heffron, R.; Donnell, D.; Rees, H.; Celum, C.; Mugo, N.; Were, E.; de Bruyn, G.; Nakku-Joloba, E.; Ngure, K.; Kiarie, J.; Coombs, R.W.; Baeten, J.M.; Celum, C.; Wald, A.; Lingappa, J.; Baeten, J.M.; Campbell, M.; Corey, L.; Coombs, R.W.; Hughes, J.P.; Magaret, A.; McElrath, M.J.; Morrow, R.; Mullins, J.I.; Coetzee, D.; Fife, K.; Were, E.; Essex, M.; Makhema, J.; Katabira, E.; Ronald, A.; Allen, S.; Kayitenkore, K.; Karita, E.; Bukusi, E.; Cohen, C.; Allen, S.; Kanweka, W.; Allen, S.; Vwalika, B.; Kapiga, S.; Manongi, R.; Farquhar, C.; John-Stewart, G.; Kiarie, J.; Allen, S.; Inambao, M.; Delany-Moretlwe, S.; Rees, H.; de Bruyn, G.; Gray, G.; McIntyre, J.; Mugo, N.R. 2012: Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study LANCET. Infectious Diseases 12(1): 19-26
Rosenblatt, K.A.; Thomas, D.B. 1991: Hormonal content of combined oral contraceptives in relation to the reduced risk of endometrial carcinoma. the WHO Collaborative Study of Neoplasia and Steroid Contraceptives International Journal of Cancer 49(6): 870-874
Rosenblatt, K.A.; Thomas, D.B. 1991: Hormonal content of combined oral contraceptives in relation to the reduced risk of endometrial carcinoma. the WHO Collaborative Study of Neoplasia and Steroid Contraceptives International Journal of Cancer 49(6): 870-874
Rosenblatt, K.A.; Thomas, D.B. 1991: Hormonal content of combined oral contraceptives in relation to the reduced risk of endometrial carcinoma. the WHO Collaborative Study of Neoplasia and Steroid Contraceptives International Journal of Cancer 49(6): 870-874
Shulman, L.P. 2011: The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives American Journal of Obstetrics and Gynecology 205(4 Suppl): S9-13
Shulman, L.P. 2011: The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives American Journal of Obstetrics and Gynecology 205(4 Suppl): S9-13
Shulman, L.P. 2011: The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives American Journal of Obstetrics and Gynecology 205(4 Suppl): S9-13
Burke, A.E. 2011: The state of hormonal contraception today: benefits and risks of hormonal contraceptives: progestin-only contraceptives American Journal of Obstetrics and Gynecology 205(4 Suppl): S14-S17
Holck, S. 1987: Hormonal contraceptives and the risk of cancer World Health Statistics Quarterly. Rapport Trimestriel de Statistiques Sanitaires Mondiales 40(3): 225-232
Holck, S. 1987: Hormonal contraceptives and the risk of cancer World Health Statistics Quarterly. Rapport Trimestriel de Statistiques Sanitaires Mondiales 40(3): 225-232
Rosenberg, K. 2018: Hormonal Contraceptives Increase Breast Cancer Risk American Journal of Nursing 118(3): 69
Moreira, I.F.d.A.; Bianchini, M.P.; Moreira, G.R.C.; Almeida, A.M.; Rezende, B.A. 2020: Sexual function and metabolic/hormonal changes in women using long-term hormonal and non-hormonal contraceptives: a pilot study Bmc Women's Health 20(1): 240
Jick, S.S.; Jick, H. 2006: Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch Contraception 74(4): 290-292